Publicaciones en colaboración con investigadores/as de Leiden University Medical Center (1)

2008

  1. CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

    Journal of Clinical Investigation, Vol. 118, Núm. 10, pp. 3390-3402